StockDriftsStockDriftsTop 50 Affinity Asset Advisors LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ROIV | ROIVANT SCIENCES LTD | 6.49% | 3.75M | $132.7M | +33.93%(+950.00K) | $22.05(+64.18%) | 2026-06-30 | |
| APGE | APOGEE THERAPEUTICS INC | 6.41% | 987.0K | $131.0M | -23.19%(-297.93K) | $42.21(+218.75%) | 2026-06-30 | |
| SYRE | SPYRE THERAPEUTICS INC | 5.55% | 1.28M | $113.6M | +0.00%(+0) | $17.62(+488.01%) | 2026-06-30 | |
| XENE | XENON PHARMACEUTICALS INC | 4.71% | 1.59M | $96.3M | -4.78%(-80.00K) | $42.04(+48.29%) | 2026-06-30 | |
| ERAS | ERASCA INC | 4.7% | 5.25M | $96.2M | -1.87%(-100.00K) | $4.15(+342.95%) | 2026-06-30 | |
| INSM | INSMED INC | 3.39% | 650.0K | $69.3M | +35.42%(+170.00K) | $98.35(+25.81%) | 2026-06-30 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 3.03% | 185.0K | $61.9M | +8.82%(+15.00K) | $184.55(+98.76%) | 2026-06-30 | |
| ALKS | ALKERMES PLC | 2.88% | 1.13M | $58.9M | -16.67%(-225.00K) | $28.06(+74.82%) | 2026-06-30 | |
| ORKA | ORUKA THERAPEUTICS INC | 2.75% | 590.0K | $56.2M | +18.08%(+90.33K) | $29.72(+278.50%) | 2026-06-30 | |
| ANAB | ANAPTYSBIO INC | 2.73% | 826.1K | $55.8M | -41.41%(-583.89K) | $30.73(+90.27%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +38.55% | +165.99% | +11.63% | +73.37% |
| Top 20 Holdings Unweighted | +47.38% | +220.12% | +22.93% | +180.71% |
Affinity Asset Advisors LLC reports $2.21B in US-listed equity holdings across 104 positions in its most recent 13F filing. Its largest disclosed positions are ROIV (6.5%), APGE (6.4%) and SYRE (5.5%). The top 20 holdings account for 61.75% of reported assets. Its disclosed equity book has returned +165.99% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Affinity Asset Advisors LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Affinity Asset Advisors LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1773195). View Affinity Asset Advisors LLC’s 13F filings on SEC